Aandelen in “Medische Specialiteiten”

Aandeel Datum Koers Evolutie
Even geduld...

Nieuws over “Medische Specialiteiten”

28/03 · CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints · Persbericht

28/03 · CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints · Persbericht

28/03 · SLNO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 · Persbericht

28/03 · HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism · Persbericht

28/03 · Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline · Persbericht

27/03 · Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

27/03 · MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value · Persbericht

27/03 · How Decentralized AI is Unlocking Value in Cardiac Diagnostics · Persbericht

27/03 · Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures · Persbericht

27/03 · Are WBD, FONR, ULY Obtaining Fair Deals for their Shareholders? · Persbericht

27/03 · Belgisch medtechbedrijf IBA lost winstbelofte in · Tijd.be (€)

Het Waalse IBA, een specialist in technologie voor kankertherapie, lost met een bedrijfswinst van 27,4 miljoen euro zijn belofte in.

27/03 · IBA delivers strong FY 2025 results with solid execution in all segments    · Persbericht

26/03 · Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman · Persbericht

26/03 · Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO · Persbericht

26/03 · FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair · Persbericht

26/03 · Beleggersagenda van vrijdag 27 maart: IBA opent de boeken · Tijd.be (€)

De specialist in protontherapie voor kankerbestrijding IBA beloofde over boekjaar 2025 minstens 25 miljoen euro bedrijfswinst voor te leggen.

26/03 · Abbott hosts conference call for first-quarter earnings · Persbericht

26/03 · COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE · Persbericht

26/03 · Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results · Persbericht

25/03 · Atossa Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides a Corporate Update · Persbericht

25/03 · Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

Mijn selecties